CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
79 hedge funds and large institutions have $195M invested in Concert Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
-6
Holders Change %
-7.06%
% of All Funds
1.97%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
12
Increased
26
Reduced
23
Closed
16
Calls
$572K
Puts
$1.08M
Net Calls
-$510K
Net Calls Change
-$601K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$6.63M |
| 2 |
LSC
Lyon Street Capital
Sausalito,
California
|
$6.07M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
$5.05M |
| 4 |
QI
QS Investors
New York
|
$1.29M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$10.6M |
